Ryding Neil Mr. 4
4 · HAEMONETICS CORP · Filed May 23, 2018
Insider Transaction Report
Form 4
Ryding Neil 122-62-507
EVP, Global Manufacturing
Transactions
- Sale
Common Stock
2016-10-20$34.16/sh−351$11,990→ 19,325 total - Sale
Common Stock
2017-10-25$46.76/sh−267$12,485→ 15,409 total - Sale
Common Stock
2017-10-20$45.70/sh−346$15,812→ 15,676 total - Tax Payment
Common Stock
2017-01-13$40.32/sh−3,303$133,177→ 16,022 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This number includes unvested restricted stock units previously reported.